Acute Psychosis in an Adolescent Girl During Treatment for Advanced Nodular Lymphocyte-Predominant Hodgkin's Lymphom

Key words

nodular lymphocyte-predominant Hodgkin lymphoma - prednisone - psychosis - rituximab

Schlüsselwörter

noduläres lymphozyten-prädominantes Hodgkin-Lymphom - Prednison - Psychose - Rituximab

Literatur

• 1 Azim Jr HA, Pruneri G, Cocorocchio E. et al . Rituximab in lymphocyte-predominant Hodgkin's disease.  Oncology. 2009;  76 26-29
• 2 Carney MW, Ravindran A, Lewis DS. Manic psychosis associated with procarbazine.  Br Med J (Clin Res Ed). 1982;  284 82-83
• 3 Ekstrand BC, Lucas JB, Horwitz SM. et al . Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial.  Blood. 2003;  101 4285-4289
• 4 Freim Wahl SG, Folvik MR, Torp SH. Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: Case report and review of the literature.  Clin Neuropathol. 2007;  26 68-73
• 5 Hall GW, Katzilakis N, Pinkerton CR. et al . Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma – a Children's Cancer and Leukaemia Group report.  Br J Haematol. 2007;  138 761-768
• 6 Hall RC, Popkin MK, Stickney SK. et al . Presentation of the steroid psychoses.  J Nerv Ment Dis. 1979;  167 229-236
• 7 Hergrüner S, Bilge I, Yavuz Yilmaz A. et al . Steroid-induced psychosis in an adolescent: treatment and prophylaxis with risperidone.  Turk J Pediatr. 2006;  48 244-247
• 8 Imbach P. When a child with immune thrombocytopenia experiences life-threatening bleeding.  Klin Padiatr. 2010;  222 337-339
• 9 Janka G. Hemophagocytic lymphohistiocytosis: When the immune system runs amok.  Klin Padiatr. 2009;  221 278-285
• 10 Klingebiel T, Creutzig U, Christaras A. et al . Milestones of health policy and rare diseases.  Klin Padiatr. 2010;  222 121-123
• 11 Landgraf M, Siekmeyer M, Fischer L U. et al . Coincidence of immune thrombocytopenia, intracranial hemorrhage and graft-versus-host disease in an 11-year-old girl.  Klin Padiatr. 2010;  222 378-382
• 12 Lewis DA, Smith RE. Steroid-induced psychiatric syndromes. A report of 14 cases and a review of the literature.  J Affect Disord. 1983;  5 319-332
• 13 Maeda L, Advani R. The emerging role for rituximab in the treatment of nodular lymphocyte predominant Hodgkin lymphoma.  Curr Opin Oncol. 2009;  21 397-400
• 14 Mauz-Körholz C, Hasenclever D, Dörffel W. et al . Procarbazine-free OEPA-COPDAC chemotherapy in boys and standard OPPA-COPP in girls have comparable effectiveness in pediatric Hodgkin's lymphoma: The GPOH-HD-2002 Study.  J Clin Oncol 2010;  28 3680-3686
• 15 Mian I, Gearing R, Desouza C. et al . Corticosteroid-related psychiatric complications in the treatment of Hodgkin's lymphoma in adolescents.  J Can Acad Child Adolesc Psychiatry. 2007;  16 27-29
• 16 Nogová L, Rudiger T, Engert A. Biology, clinical course and management of nodular lymphocyte-predominant hodgkin lymphoma.  Hematology Am Soc Hematol Educ Program. 2006;  266-272
• 17 Rehwald U, Schulz H, Reiser M. et al . Treatment of relapsed CD20+ Hodgkin lymphoma with the monoclonal antibody rituximab is effective and well tolerated: Results of a phase 2 trial of the German Hodgkin Lymphoma Study Group.  Blood. 2003;  101 420-424
• 18 Schulz H, Rehwald U, Morschhauser F. et al . Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: Long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG).  Blood. 2008;  111 109-111
• 19 Strian F, Maurach R. Cytostatic therapy: Neurologic and psychiatric syndromes.  Med Klin. 1980;  75 478-484
• 20 Stuart FA, Segal TY, Keady S. Adverse psychological effects of corticosteroids in children and adolescents.  Arch Dis Child. 2005;  90 500-506

Korrespondenzadresse